Skip to content
2000
Volume 22, Issue 4
  • ISSN: 1573-4072
  • E-ISSN: 1875-6646

Abstract

Inflammation is a defense response of the body that occurs due to injury or bacterial infection, allergens, autoimmune disease, . PGs (Prostaglandins), leukotrienes, histamine, BK (bradykinin), and ILs (interleukins) are the main chemical mediators involved in inflammation and its associated diseases. The major pathway is the formation of arachidonic acid connected with the cyclooxygenase (COX) enzyme and 5-lipoxygenase enzyme in the synthesis of prostaglandins and leukotrienes, respectively. Anti-inflammatory agents primarily target cyclooxygenases (COX 1 and 2), phospholipase A2 (PLA2), and lipoxygenase (LOX). Some major patents are covered in this review article. This review also covers the journey of anti-inflammatory activities of tetrahydrocarbazole structure-based derivatives from 1976 till date. Researchers around the world have designed and synthesized novel tetrahydrocarbazoles based on the indomethacin structure under the NSAIDs category using Structure-based Drug Design (SBBD), which have displayed significant and anti-inflammatory activities. Tetrahydrocarbazole structures linked with other potential pharmacophores, including chalconyl, isoxazolinyl, pyrazolinyl and diazoles, have also been evaluated for anti-inflammatory activities. Major substitutions, either halogen or electron-releasing groups on tetrahydrocarbazole structure, play a crucial role in its anti-inflammatory activities. Moreover, reported N-9 substituted tetrahydrocarbazoles have been observed to display significant anti-inflammatory activities. These THCz derivatives target the COX-2 enzyme, which plays a crucial role in inflammation and also in cancer. Lastly, this review encourages scientists to design and synthesize novel compounds based on tetrahydrocarbazole structure to address inflammation and its associated diseases.

Loading

Article metrics loading...

/content/journals/cbc/10.2174/0115734072349578250312005557
2025-04-21
2026-03-10
Loading full text...

Full text loading...

References

  1. AhmedA.U. An overview of inflammation: Mechanism and consequences.Front. Biol.20116427428110.1007/s11515‑011‑1123‑9
    [Google Scholar]
  2. HussainT. TanB. YinY. BlachierF. TossouM.C.B. RahuN. Oxidative stress and inflammation: What polyphenols can do for us?Oxid. Med. Cell. Longev.201620161743279710.1155/2016/7432797
    [Google Scholar]
  3. KimY.S. YoungM.R. BobeG. ColburnN.H. MilnerJ.A. Bioactive food components, inflammatory targets, and cancer prevention.Cancer Prev. Res.20092320020810.1158/1940‑6207.CAPR‑08‑0141
    [Google Scholar]
  4. KamatV. SantoshR. PoojaryB. NayakS.P. KumarB.K. SankaranarayananM. Pyridine-and thiazole-based hydrazides with promising anti-inflammatory and antimicrobial activities along with their in silico studies.ACS Omega2020539252282523910.1021/acsomega.0c03386
    [Google Scholar]
  5. NarasimhamurthyK.H. SwaroopT.R. RangappaK.S. A review on progress of thiazole derivatives as potential anti-inflammatory agents.Eur. J. Med. Chem. Rep.20241210022510.1016/j.ejmcr.2024.100225
    [Google Scholar]
  6. DaviesJ.A. Arachidonic acid.xPharm20081410.1016/B978‑008055232‑3.63337‑9
    [Google Scholar]
  7. TiwariA. MishraB. Diverse pharmacological actions of potential carbazole derivatives by influencing various pathways of molecular signaling.Future J. Pharm. Sci.20241017710.1186/s43094‑024‑00650‑0
    [Google Scholar]
  8. WangD. DuBoisR.N. Prostaglandins and cancer.Gut200655111512210.1136/gut.2004.047100
    [Google Scholar]
  9. ThuyT.T.T. CuongN.M. ToanT.Q. ThangN.N. TaiB.H. NhiemN.X. HongH.J. KimS. LegoupyS. KohY.S. KimY.H. Synthesis of novel derivatives of murrayafoline A and their inhibitory effect on LPS-stimulated production of pro-inflammatory cytokines in bone marrow-derived dendritic cells.Arch. Pharm. Res.201336783283910.1007/s12272‑013‑0100‑z
    [Google Scholar]
  10. GhaniA. SadiqZ. IqbalS. YasmeenA. ShujaatS. AliI. Screening of anti-inflammatory and antioxidant potential of functionalized tetrahydrocarbazole linked 1,2-diazoles and their docking studies.Arab. J. Chem.2022151110419510.1016/j.arabjc.2022.104195
    [Google Scholar]
  11. KasimS.M. Al-DabbaghB.M. MustafaY.F. A review on the biological potentials of carbazole and its derived products.Eurasian Chem. Commun.202246495512
    [Google Scholar]
  12. KurumbailR.G. StevensA.M. GierseJ.K. McDonaldJ.J. StegemanR.A. PakJ.Y. GildehausD. iyashiroJ.M. PenningT.D. SeibertK. IsaksonP.C. StallingsW.C. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents.Nature1996384661064464810.1038/384644a0
    [Google Scholar]
  13. LimongelliV. BonomiM. MarinelliL. GervasioF.L. CavalliA. NovellinoE. ParrinelloM. Molecular basis of cyclooxygenase enzymes (COXs) selective inhibition.Proc. Natl. Acad. Sci. USA2010107125411541610.1073/pnas.0913377107
    [Google Scholar]
  14. MuzamilA. TahirH.M. AliS. LiaqatI. AliA. SummerM. Inflammatory process and role of cytokines in inflammation: An overview.Punjab Univ. J. Zool2021362235250
    [Google Scholar]
  15. ElgazarA.A. KnanyH.R. AliM.S. Insights on the molecular mechanism of anti-inflammatory effect of formula from Islamic traditional medicine: An in-silico study.J. Tradit. Complement. Med.20199435336310.1016/j.jtcme.2018.09.004
    [Google Scholar]
  16. DinarelloC.A. Anti-inflammatory agents: Present and future.Cell2010140693595010.1016/j.cell.2010.02.043
    [Google Scholar]
  17. BehlT. RanaT. AlotaibiG.H. ShamsuzzamanM. NaqviM. SehgalA. SinghS. SharmaN. AlmoshariY. AbdellatifA.A.H. IqbalM.S. BhatiaS. Al-HarrasiA. BungauS. Polyphenols inhibiting MAPK signalling pathway mediated oxidative stress and inflammation in depression.Biomed. Pharmacother.202214611254510.1016/j.biopha.2021.112545
    [Google Scholar]
  18. KassabS.E. Indomethacin from anti-inflammatory to anticancer agent. Medicinal Chemistry.IntechOpen2018
    [Google Scholar]
  19. NishaV.T. A concise review on tetrahydrocarbazoles and its biological activities.World J. Pharm. Res.2024131642649
    [Google Scholar]
  20. NitinK. ShaliniS. SaurabhA. VisheshV. Antibacterial potential of Tetrahydrocarbazoles (THCZ): A review.Curr. Bioact. Compd.20242010e060224226733
    [Google Scholar]
  21. KumarN. GuptaP. Anticancer Tetrahydrocarbazoles: A wide journey from 2000 till date.Lett. Drug Des. Discov.202421342143910.2174/1570180820666221028163319
    [Google Scholar]
  22. SarkarS. MakvanaS. HiraniD. MakadiaI. DholariyaK. DhokiaH. VanpariyaN. Tetrahydrocarbazoles as potential therapeutic agents: A review of their synthesis and biological activities.WJARR20232132127213510.30574/wjarr.2024.21.3.0935
    [Google Scholar]
  23. LuthraP.M. KumarN. Progress and development of C-3, C-6, and N-9 positions substituted carbazole integrated molecular hybrid molecules as potential anticancer agents.Mini Rev. Med. Chem.202121192929295610.2174/1389557521666210521221808
    [Google Scholar]
  24. WangL.L. DuY. LiS.M. ChengF. ZhangN.N. ChenR. CuiX. YangS.G. FanL.L. WangJ.T. GuoB. WuH-S. ZhangJ-Q. TangL. Design, synthesis and evaluation of tetrahydrocarbazole derivatives as potential hypoglycemic agents.Bioorg. Chem.202111510517210.1016/j.bioorg.2021.105172
    [Google Scholar]
  25. El-NassanH.B. Synthesis and antitumor activity of tetrahydrocarbazole hybridized with dithioate derivatives.J. Enzyme Inhib. Med. Chem.201530230831510.3109/14756366.2014.922554
    [Google Scholar]
  26. ChaudhariT.Y. TandonV. Recent approaches to the synthesis of tetrahydrocarbazoles.Org. Biomol. Chem.20211991926193910.1039/D0OB02274H
    [Google Scholar]
  27. SurendiranT. Studies on anti-inflammatory behaviour of chalconyl, isoxazolinyl and pyrazolinyl 1,2,3,4-tetrahydrocarbazoles.Studies20158183e188
    [Google Scholar]
  28. KumarN. Kumar, Vinod.; Chowdhary, Yogita. A review on synthesis methods of tricyclic 1,2,3,4-tetrahydrocarbazoles.WJARR202213116017110.30574/wjarr.2022.13.1.0754
    [Google Scholar]
  29. VermaV. SharmaS. GaurK. KumarN. Role of vinca alkaloids and their derivatives in cancer therapy.WJARR202216379480010.30574/wjarr.2022.16.3.1378
    [Google Scholar]
  30. GuptaA. Kalantar-ZadehK. ReddyS.T. Ramatroban as a novel immunotherapy for COVID-19.J. Mol. Genet. Med.2020143
    [Google Scholar]
  31. RubioF. SeawallS. PocelinkoR. DebarbieriB. BenzW. BergerL. MorganL. PaoJ. WilliamsT.H. KoechlinB. Metabolism of carprofen, a nonsteroidal anti-inflammatory agent, in rats, dogs, and humans.J. Pharm. Sci.198069111245125310.1002/jps.2600691104
    [Google Scholar]
  32. MahdiM.H. DawoodA.H. ShaheedD.Q. Substituted tetrahydrocarbazole based on indomethacin and diclofenac with heterocyclic compound, synthesis, spectral and antimicrobial studies.J. Med. Chem. Sci.202256933942
    [Google Scholar]
  33. MahdiM.H. DawoodA.H. ShaheedD.Q. Synthesis and study of antimicrobial activity of some tetrahydrocarbazole derivatives substituted with NSAID.AJPS2022222445410.32947/ajps.v22i2.857
    [Google Scholar]
  34. SakinalaP. ChikhaleR. TajneM. Design, synthesis and pharmacological evaluation of some novel tetrahydrocarbazoles as potential COX-2 inhibitors.Lett. Drug Des. Discov.201815443744910.2174/1570180814666170602084037
    [Google Scholar]
  35. CampaigneE. LakeR.D. Synthesis of tetrahydrocarbazoles and carbazoles by the bischler reaction1,2.J. Org. Chem.195924447848710.1021/jo01086a010
    [Google Scholar]
  36. RogersC.U. CorsonB.B. One-Step Synthesis of 1,2,3,4-Tetrahydrocarbazole and 1,2-Benzo-3,4-dihydrocarbazole.J. Am. Chem. Soc.194769112910291110.1021/ja01203a506
    [Google Scholar]
  37. CampbellN. BarclayB.M. Recent advances in the chemistry of carbazole.Chem. Rev.194740335938010.1021/cr60127a001
    [Google Scholar]
  38. BerlinK.D. Synthesis of 1,2,3,4-Tetrahydrocarbazoles with large Group-Aromatization to Carbazoles.Proceedings of the Oklahoma Academy of Science 1967 Feb 5, pp. 215-220.
    [Google Scholar]
  39. KocienskiP. Synthesis of (R)-Ramatroban.Synfacts2012880822
    [Google Scholar]
  40. ManchandP.S. CoffenD.L. BelicaP.S. WongF. WongH.S. BergerL. Syntheses of carprofen, a carbazole-based non-steroidal anti-inflammatory agent.Heterocycles199423983384510.3987/COM‑94‑S(B)83
    [Google Scholar]
  41. KumarN. LavhaleP.M. NSAID carprofen structure-based derivatives as potential antibacterial agents.AJPRD2024125525810.22270/ajprd.v12i5.1478
    [Google Scholar]
  42. FoxS.M. JohnstonS.A. Use of carprofen for the treatment of pain and inflammation in dogs.J. Am. Vet. Med. Assoc.1997210101493149810.2460/javma.1997.210.10.1493
    [Google Scholar]
  43. BurgerL. CorrazJ. Carbazoles.US Patent 3,896,1451975
    [Google Scholar]
  44. Organon Labor Ltd. Anti-inflammatory preparations containing tetrahydrocarbazole derivatives.UK Patent GB1358098A1974
    [Google Scholar]
  45. GuindonY. Tetrahydrocarbazole 1-alkanoic acids.EP Patent No. 0300676 A21988
    [Google Scholar]
  46. MobilioD. ParkF. 2,3,4,9-tetrahydro-1H-carbazole acetic acid derivatives, composition and use as anti-inflammatories.US Patent 4,927,8421990
    [Google Scholar]
  47. GuindonY. GillardJ.W. YoakimC. Tetrahydrocarbazole esters.EP Patent 0239306-B11989
    [Google Scholar]
  48. HunterS.T. Substituted tetrahydrocarbazole and carbazole carboxamide compounds.US Patent 9,850,258 B22017
    [Google Scholar]
  49. FailliA.A. SteffanR.J. KreftA.F. CaggianoT.J. CaufieldE. Pyranoindole and tetrahydro carbazole inhibitors of COX-2.US Patent 5,830,911,19881988
    [Google Scholar]
  50. AsselinA.A. HumberL.G. DobsonT.A. KomlossyJ. MartelR.R. Syntheses and antiinflammatory actions of some acidic tetrahydrocarbazoles, cyclopentindoles, and cycloheptindoles.J. Med. Chem.197619678779210.1021/jm00228a010
    [Google Scholar]
  51. ConneyA.H. CoutinhoC. KoechlinB. SwarmR. CheripkoJ.A. ImpellizzeriC. BaruthH. From animals to man: Metabolie eonsiderations.Clin. Pharmacol. Ther.1974161part217618210.1002/cpt1974161part2176
    [Google Scholar]
  52. MobilioD. HumberL.G. KatzA.H. DemersonC.A. HughesP. BriganceR. ConwayK. ShahU. WilliamsG. Structure-activity relationships among analogues of pemedolac, cis-1-ethyl-1,3,4,9-tetrahydro-4-(phenylmethyl)pyrano[3,4-b]indole-1-acetic acid, a potent analgesic agent.J. Med. Chem.198831112211221710.1021/jm00119a024
    [Google Scholar]
  53. KatzA.H. DemersonC.A. ShawC.C. AsselinA.A. HumberL.G. ConwayK.M. GavinG. GuinossoC. JensenN.P. Synthesis and analgesic activity of pemedolac [cis-1-ethyl-1,3,4,9-tetrahydro-4-(phenylmethyl)pyrano[3,4-b]indole-1-acetic acid].J. Med. Chem.19883161244125010.1021/jm00401a029
    [Google Scholar]
  54. LankaS. Synthesis of N-subs compounds. Int. Int. J. Curnt. Tren.Pharm. Res.201532839
    [Google Scholar]
  55. KassabS.E. KhedrM.A. AliH.I. AbdallaM.M. Discovery of new indomethacin-based analogs with potentially selective cyclooxygenase-2 inhibition and observed diminishing to PGE2 activities.Eur. J. Med. Chem.201714130632110.1016/j.ejmech.2017.09.056
    [Google Scholar]
  56. da Silva GuerraA.S.H. do Nascimento MaltaD.J. Morais LaranjeiraL.P. Souza MaiaM.B. Cavalcanti ColaçoN. do Carmo Alves de LimaM. GaldinoS.L. da Rocha PittaI. Gonçalves-SilvaT. Anti-inflammatory and antinociceptive activities of indole–imidazolidine derivatives.Int. Immunopharmacol.201111111816182210.1016/j.intimp.2011.07.010
    [Google Scholar]
/content/journals/cbc/10.2174/0115734072349578250312005557
Loading
/content/journals/cbc/10.2174/0115734072349578250312005557
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test